Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
CHINA OILFIELD
02883
5
CNOOC
00883
| (Q6)Jun 30, 2025 | (FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash flow from operating activities | ||||||||||
| Earning before tax | ---- | -239.24%-88.64M | ---- | 87.15%-26.13M | ---- | -69.11%-203.42M | ---- | -36.94%-120.29M | ---- | 50.91%-87.84M |
| Profit adjustment | ||||||||||
| Interest (income) - adjustment | ---- | 65.08%-22K | ---- | 52.63%-63K | ---- | 74.86%-133K | ---- | 52.21%-529K | ---- | 18.42%-1.11M |
| Investment loss (gain) | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -74.92%78K | ---- | --311K |
| Impairment and provisions: | ---- | 182.96%8.49M | ---- | -136.62%-10.23M | ---- | 225.62%27.93M | ---- | -135.10%-22.24M | ---- | 51.56%63.35M |
| -Impairment of property, plant and equipment (reversal) | ---- | --56K | ---- | ---- | ---- | ---- | ---- | -62.59%4.85M | ---- | 452.17%12.95M |
| -Impairmen of inventory (reversal) | ---- | 101.78%491K | ---- | -237.26%-27.62M | ---- | 152.41%20.12M | ---- | -196.36%-38.4M | ---- | 220.04%39.85M |
| -Impairment of trade receivables (reversal) | ---- | -92.75%1.19M | ---- | 123.83%16.45M | ---- | 60.25%7.35M | ---- | 142.43%4.59M | ---- | -169.39%-10.81M |
| -Other impairments and provisions | ---- | 615.48%6.75M | ---- | 104.56%943K | ---- | -93.15%461K | ---- | -68.49%6.73M | ---- | 86.94%21.35M |
| Revaluation surplus: | ---- | -83.63%1.54M | ---- | 3,110.58%9.41M | ---- | --293K | ---- | ---- | ---- | -82.91%-14.24M |
| -Derivative financial instruments fair value (increase) | ---- | 75.08%-76K | ---- | -204.10%-305K | ---- | --293K | ---- | ---- | ---- | ---- |
| -Other fair value changes | ---- | -83.36%1.62M | ---- | --9.71M | ---- | ---- | ---- | ---- | ---- | -170.93%-14.24M |
| Asset sale loss (gain): | ---- | -50.42%237K | ---- | 122.42%478K | ---- | 69.90%-2.13M | ---- | 80.85%-7.08M | ---- | -246,553.33%-37M |
| -Loss (gain) from sale of subsidiary company | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 85.72%-8.25M | ---- | ---57.76M |
| -Loss (gain) on sale of property, machinery and equipment | ---- | -50.42%237K | ---- | 122.42%478K | ---- | -282.85%-2.13M | ---- | -92.56%1.17M | ---- | 104,613.33%15.68M |
| -Loss (gain) from selling other assets | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --5.09M |
| Depreciation and amortization: | ---- | -21.22%23.66M | ---- | 110.12%30.04M | ---- | 22.05%14.3M | ---- | -70.63%11.71M | ---- | -33.31%39.88M |
| Financial expense | ---- | 42.19%19.89M | ---- | 86.50%13.99M | ---- | -66.61%7.5M | ---- | 27.73%22.47M | ---- | -40.03%17.59M |
| Special items | ---- | 109.27%6.79M | ---- | -6,449.70%-73.21M | ---- | 151.75%1.15M | ---- | 104.01%458K | ---- | -238.68%-11.43M |
| Operating profit before the change of operating capital | ---- | 49.64%-28.06M | ---- | 63.93%-55.72M | ---- | -33.87%-154.51M | ---- | -278.60%-115.42M | ---- | 37.70%-30.49M |
| Change of operating capital | ||||||||||
| Inventory (increase) decrease | ---- | -71.77%7.39M | ---- | -31.25%26.19M | ---- | -69.68%38.1M | ---- | 390.66%125.66M | ---- | -218.65%-43.23M |
| Accounts receivable (increase)decrease | ---- | -1,493.51%-1.07M | ---- | -95.16%77K | ---- | -98.29%1.59M | ---- | 16.39%93.09M | ---- | -80.25%79.98M |
| Accounts payable increase (decrease) | ---- | 14.17%-12.94M | ---- | -200.13%-15.08M | ---- | 116.45%15.06M | ---- | 26.90%-91.56M | ---- | -32.55%-125.25M |
| prepayments (increase)decrease | ---- | -97.30%904K | ---- | 184.63%33.48M | ---- | -156.16%-39.56M | ---- | -23.46%70.45M | ---- | 161.54%92.04M |
| Special items for working capital changes | ---- | -9.76%-4.97M | ---- | -103.46%-4.53M | ---- | 63.22%-2.23M | ---- | -58.60%-6.05M | ---- | -332.56%-3.81M |
| Cash from business operations | ---- | -148.70%-38.75M | ---- | 88.99%-15.58M | ---- | -285.82%-141.55M | ---- | 347.65%76.18M | ---- | -120.49%-30.76M |
| Other taxs | ---- | ---- | ---- | --68K | ---- | ---- | ---- | 104.64%730K | ---- | 8.38%-15.74M |
| Special items of business | 129.56%6.02M | ---- | 41.59%-20.37M | ---- | -239.13%-34.88M | ---- | 94.19%-10.28M | ---- | -310.76%-177.15M | ---- |
| Net cash from operations | 129.56%6.02M | -149.79%-38.75M | 41.59%-20.37M | 89.04%-15.51M | -239.13%-34.88M | -284.06%-141.55M | 94.19%-10.28M | 265.40%76.91M | -310.76%-177.15M | -134.98%-46.5M |
| Cash flow from investment activities | ||||||||||
| Interest received - investment | 50.00%6K | -65.08%22K | -92.45%4K | -52.63%63K | 76.67%53K | -74.86%133K | -90.74%30K | -52.21%529K | -52.00%324K | -18.42%1.11M |
| Loan receivable (increase) decrease | ---- | 109.06%60K | -99.24%55K | -119.84%-662K | 147.81%7.28M | 105.24%3.34M | ---15.23M | ---63.64M | ---- | ---- |
| Decrease in deposits (increase) | ---- | ---- | ---- | -99.92%12K | ---- | -73.58%14.67M | -35.57%14.67M | -8.90%55.53M | -27.67%22.76M | 259.21%60.96M |
| Sale of fixed assets | --106K | -13.03%407K | ---- | -80.04%468K | --168K | 711.42%2.35M | ---- | -99.60%289K | ---- | 267,222.22%72.18M |
| Purchase of fixed assets | -833.06%-1.13M | 79.07%-836K | 93.51%-121K | 68.28%-3.99M | 62.98%-1.87M | -400.80%-12.59M | -174.40%-5.04M | 96.31%-2.51M | 97.12%-1.84M | -141.67%-68.04M |
| Sale of subsidiaries | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -91.53%8.71M | --34.84M | --102.83M |
| Cash on investment | ---- | ---- | ---- | ---11.15M | ---11.13M | ---- | ---- | ---- | ---- | ---- |
| Other items in the investment business | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 847.42%16.96M |
| Net cash from investment operations | -1,540.32%-1.02M | 97.73%-347K | 98.87%-62K | -293.28%-15.26M | 1.37%-5.49M | 816.52%7.9M | -109.93%-5.57M | -100.59%-1.1M | -4.68%56.09M | 296.42%185.99M |
| Net cash before financing | 124.49%5M | -27.04%-39.09M | 49.38%-20.43M | 76.98%-30.77M | -154.67%-40.37M | -276.32%-133.66M | 86.91%-15.85M | -45.66%75.8M | -184.72%-121.06M | 264.82%139.49M |
| Cash flow from financing activities | ||||||||||
| New borrowing | -93.72%4.35M | -13.37%134.44M | -38.77%69.32M | 68.59%155.18M | 138.03%113.21M | -51.34%92.05M | -89.30%47.56M | -73.03%189.18M | 91.78%444.66M | 45.00%701.58M |
| Refund | 14.48%-23.83M | 40.68%-59.03M | 53.37%-27.87M | -48.44%-99.51M | -73.56%-59.76M | 73.02%-67.04M | 88.00%-34.43M | 69.97%-248.44M | 16.48%-286.96M | -68.73%-827.34M |
| Issuing shares | --25.79M | ---- | ---- | ---- | ---- | --119.33M | --19.6M | ---- | ---- | ---- |
| Interest paid - financing | 56.24%-2.29M | -128.61%-13.46M | -201.90%-5.24M | -211.81%-5.89M | -32.14%-1.74M | 89.39%-1.89M | 86.29%-1.31M | -99.80%-17.8M | -54.59%-9.58M | -13.16%-8.91M |
| Issuance expenses and redemption of securities expenses | ---110K | ---- | ---- | ---- | ---- | ---1.35M | ---236K | ---- | ---- | ---- |
| Other items of the financing business | --6K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Net cash from financing operations | -116.65%-3.94M | 101.89%38.4M | -35.14%23.65M | -84.51%19.02M | 59.79%36.47M | 227.04%122.79M | -83.59%22.82M | 44.22%-96.66M | 195.28%139.09M | -107.40%-173.28M |
| Effect of rate | 40.82%-287K | -100.66%-59K | -176.98%-485K | 79.40%8.92M | -92.32%630K | 405.10%4.97M | 2,984.96%8.21M | -26.67%-1.63M | 111.52%266K | 83.01%-1.29M |
| Net Cash | -66.88%1.07M | 94.09%-695K | 182.60%3.22M | -8.17%-11.75M | -155.89%-3.9M | 47.90%-10.87M | -61.31%6.97M | 38.28%-20.86M | 685.61%18.03M | 25.43%-33.79M |
| Begining period cash | -15.86%4M | -37.38%4.75M | -37.38%4.75M | -43.72%7.59M | -43.72%7.59M | -62.51%13.49M | -62.51%13.49M | -49.37%35.97M | -49.37%35.97M | -42.67%71.05M |
| Cash at the end | -36.18%4.78M | -15.86%4M | 73.19%7.49M | -37.38%4.75M | -84.92%4.32M | -43.72%7.59M | -47.17%28.66M | -62.51%13.49M | -17.36%54.26M | -49.37%35.97M |
| Cash balance analysis | ||||||||||
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | -- | -- | -- | -- | -- | -- | -- | -- | -- | Unqualified Opinion |
| Auditor | -- | National Health Accounting Firm Co., Ltd. | -- | National Health Accounting Firm Co., Ltd. | -- | National Health Accounting Firm Co., Ltd. | -- | National Health Accounting Firm Co., Ltd. | -- | National Health Accounting Firm Co., Ltd. |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.